4.4 Article

CTCF and BORIS in genome regulation and cancer

Journal

CURRENT OPINION IN GENETICS & DEVELOPMENT
Volume 24, Issue -, Pages 8-15

Publisher

CURRENT BIOLOGY LTD
DOI: 10.1016/j.gde.2013.10.011

Keywords

-

Funding

  1. Cancer Council NSW [RG11-12]
  2. Cure the Future (Cell and Gene Trust)
  3. Scott Canner Memorial Research Fellowship from Tour de Cure

Ask authors/readers for more resources

CTCF plays a vital role in chromatin structure and function. CTCF is ubiquitously expressed and plays diverse roles in gene regulation, imprinting, insulation, intra/interchromosomal interactions, nuclear compartmentalisation, and alternative splicing. CTCF has a single paralogue, the testes-specific CTCF-like gene (CTCFL)/BORIS. CTCF and BORIS can be deregulated in cancer. The tumour suppressor gene CTCF can be mutated or deleted in cancer, or CTCF DNA binding can be altered by epigenetic changes. BORIS is aberrantly expressed frequently in cancer, leading some to propose a pro-tumourigenic role for BORIS. However, BORIS can inhibit cell proliferation, and is mutated in cancer similarly to CTCF suggesting BORIS activation in cancer may be due to global genetic or epigenetic changes typical of malignant transformation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available